Frequent versus standard hemodialysis [2]

New England Journal of Medicine

Volumn 364, Issue 10, 2011, Pages 975-976

  Agarwal, Rajiv ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BODY COMPOSITION; DISEASE ASSOCIATION; EXTRACELLULAR FLUID; HEART LEFT VENTRICLE HYPERTROPHY; HEART VOLUME; HEMODIALYSIS; HUMAN; HYPERTENSION; HYPERVOLEMIA; KIDNEY FUNCTION; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT PLANNING; WEIGHT REDUCTION; CHRONIC KIDNEY FAILURE; METHODOLOGY; NOTE; RENAL REPLACEMENT THERAPY;

HUMANS; KIDNEY FAILURE, CHRONIC; OUTCOME ASSESSMENT (HEALTH CARE); RENAL DIALYSIS; EXTRACELLULAR FLUID;

EID: 79952777182     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Agarwal R, Weir MR. Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. Clin J Am Soc Nephrol 2010;5:1255-60.
2. Agarwal R, Alborzi P, Satyan S, Light RP. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009;53:500-7.